Biotech News
-
Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London to Begin Delivering Treatments
London Clinic Will Begin Delivering Ketamine-Assisted Therapy for Addiction & Mental Health Third Location Adds to Two Existing…
-
Valeo Pharma to Host First Quarter 2022 Results Conference Call / Webcast and Attend the 8th Annual AlphaNorth Capital Conference
March 17, 2022 (Source) – Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a…
-
Awakn Life Sciences Appoints Kevin Lorenz as U.S. Head of Commercial Development
Brings Over 20 Years of Commercial Biotech Experience to Lead Awakn’s Therapeutics Commercialization Activities in the U.S. March…
-
IXOS(R) Test Work Results in Outstanding Gold Adsorption Efficiency and Recovery at Client Mine Site
March 15, 2022 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”) is pleased to…
-
Sixth Wave Innovations Inc. Partners with TraceSafe for Breakthrough Agriculture Safety and Virus Detection Technology
Companies will join forces to create animal safety solutions using advanced IoT and pioneering nanotechnology to detect pathogens…
-
Zentek Reports on Icephobic Testing
March 14, 2022 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (TSX-V:ZEN and OTC:ZENYF), a Canadian IP (Intellectual Property) development…
-
Sixth Wave Highlights its IXOS(R) Gold Adsorption and Recovery Efficiencies as Gold Bullion Hits All-Time Price
March 10, 2022 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (the “Company” or “Sixth Wave”) is pleased…
-
Zentek Engages Vimta Labs for Clinical Research
March 10, 2022 (Source) — Zentek Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian IP (Intellectual Property)…
-
Clarification on Intellectual Property Matters
March 9, 2022 (Source) — Zentek Ltd. (“ZEN” or the “Company”)(TSX-V:ZEN and OTC PINK:ZENYF), wants to clarify that the technology…
-
Awakn Life Sciences to Participate at Upcoming March 2022 Conferences
March 9, 2022 (Source) — Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a biotechnology company,…
